MOTS

Motus GI Holdings, Inc. MOTS

MOTS
Motus GI Holdings, Inc. IMRSQ
IMRIS Inc. MICRD
Micron Solutions, Inc. ONCSQ
OncoSec Medical Incorporated BIIO
Bionovate Technologies Corp ROSGQ
Rosetta Genomics Ltd. HRAL
Hear AtLast Holdings, Inc. ATRX
Adhera Therapeutics, Inc. CNNXF
CannAmerica Brands Corp. STBV
Strategic Global Investments, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MOTS IMRSQ MICRD ONCSQ BIIO ROSGQ HRAL ATRX CNNXF STBV
6M -66.67 % 0.00 % 0.00 % 900.00 % 0.00 % 0.00 % -20.00 % 0.00 % 0.00 % 0.00 %
YTD -50.00 % 0.00 % 0.00 % 900.00 % 0.00 % 0.00 % -11.11 % 0.00 % 900.00 % 0.00 %
1Y 0.00 % 0.00 % -99.98 % 900.00 % -99.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 %
3Y -99.99 % 100.00 % -99.99 % -99.94 % 99 999 900.00 % 0.00 % -71.43 % -99.99 % -99.88 % 900.00 %
5Y -100.00 % 900.00 % -100.00 % -100.00 % 544.33 % -99.94 % -94.67 % -100.00 % -99.96 % 900.00 %
10Y -100.00 % 900.00 % -100.00 % -100.00 % -94.87 % -100.00 % -98.86 % -100.00 % -100.00 % 900.00 %
From the beginning -100.00 % 900.00 % -100.00 % -97.71 % -60.00 % -100.00 % -100.00 % -100.00 % -100.00 % 900.00 %

Dividend